世界の幹細胞市場予測 2022-2030年

出版:Inkwood Research(インクウッドリサーチ) 出版年月:2022年9月

GLOBAL STEM CELL MARKET FORECAST 2022-2030
世界の幹細胞市場予測 2022-2030年

ページ数 220
価格
シングルユーザライセンス USD 2,500
マルチユーザライセンス USD 3,000
エンタープライズライセンス USD 4,500
種別 英文調査報告書

レポート目次  お問合せ・ご注文  価格・納期について

無料サンプル

Global Stem Cell Market by Therapeutic Application (Orthopedic Treatments, Injuries & Wounds, Oncology Disorders, Cardiovascular Disorders, Neurological Disorders, Diabetes, Other Therapeutic Applications) Market by Product (Adult Stem Cell, Human Embryonic Stem Cell, Pluripotent, Mouse/Rat Neural) Market by Technology (Cell Acquisition, Cell Production, Cryopreservation, Expansion & Sub-culture) By Geography

Inkwood Research(インクウッドリサーチ)「世界の幹細胞市場予測 2022-2030年 – GLOBAL STEM CELL MARKET FORECAST 2022-2030」は世界の幹細胞市場を調査し、主要セグメント毎に行った分析・予測結果を提供します。

主な対象セグメント

  • 治療用途
    • 整形手術
    • 怪我および傷
    • 腫瘍
    • 循環器系疾患
    • 神経系疾患
    • 糖尿病
    • その他の治療用途
  • 製品
    • 成体幹細胞
    • ヒト胚性幹細胞
    • 多能性
    • マウス/ラットの神経系
  • 技術
    • 細胞捕捉
    • 細胞産生
    • 凍結保存
    • 増殖&二次培養
  • 地域
    • 北米
    • 欧州
    • アジア太平洋地域
    • その他の地域(RoW)

KEY FINDINGS

The global stem cell market is predicted to grow with a CAGR of 8.88% during the forecasted years of 2022 to 2030. The growth of the market is determined by key drivers such as the increasing demand for stem cells in regenerative medicine, the rising &D investments in stem cell therapies and research, the growing awareness about umbilical cord stem cells, and the reduced risk of tissue rejection in transplants.

世界の幹細胞市場予測 2022-2030年
MARKET INSIGHTS

Stem cells are characterized as special human cells with the ability to develop into several different cell types, ranging from brain cells to muscle cells. In-depth research is now being done on various cell types, including mesenchymal stem cells, epithelial stem cells, resident tissue stem cells, embryonic stem cells, hematopoietic stem cells, as well as adipose-derived stem cells.

Regenerative medicine helps produce functional, living tissues to repair aged or diseased tissue; and is therefore utilized in the treatment of cardiovascular, orthopedic, neural, and autoimmune conditions. Regenerative medicine formerly included bioabsorbable scaffolds as well as other biochemical materials. Stem cell technology is also venturing into the avenue of regenerative medicine, as embryonic stem cells possess the potential to differentiate into and subsequently regenerate all kinds of tissues. As a result, the increasing demand for stem cells in regenerative medicine is anticipated to propel the global stem cell market growth.

REGIONAL INSIGHTS

The global stem cell market growth assessment comprises the evaluation of North America, the Asia-Pacific, Europe, and Rest of World. North America is projected to dominate the global market during the forecasted years on account of factors such as technological advancements in stem cell preservation and manufacturing, industry players’ substantial investments in R&D activities, and the surging public awareness of stem cell products’ therapeutic potential.

COMPETITIVE INSIGHTS

Over the forecast period, the intensity of industrial rivalry within the global stem cell market is expected to increase and remain high. Some of the top players operating in the global market are Corning Inc, GE Healthcare, Merck KGaA (Sigma Aldrich), etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

関連市場調査レポート

Inkwood Researchでは下記地域/国別の市場調査レポートも出版しています。各レポートの詳細についてはChosaReport.comまでお問合せください。

  • ASIA-PACIFIC STEM CELL MARKET FORECAST 2022-2030
    アジア太平洋地域の幹細胞市場予測 2022-2030年
  • EUROPE STEM CELL MARKET FORECAST 2022-2030
    欧州の幹細胞市場予測 2022-2030年
  • NORTH AMERICA STEM CELL MARKET FORECAST 2022-2030
    北米の幹細胞市場予測 2022-2030年
  • AUSTRALIA & NEW ZEALAND STEM CELL MARKET FORECAST 2022-2028
    オーストラリア&ニュージーランドの幹細胞市場予測 2022-2028年

目次

  1. RESEARCH SCOPE & METHODOLOGY
    • STUDY OBJECTIVES
    • SCOPE OF STUDY
    • METHODOLOGY
    • ASSUMPTIONS & LIMITATIONS
  2. EXECUTIVE SUMMARY
    • MARKET SIZE & ESTIMATES
    • MARKET OVERVIEW
  3. MARKET DYNAMICS
    • KEY DRIVERS
      • SURGING DEMAND FOR STEM CELLS IN REGENERATIVE MEDICINE
      • GROWING R&D INVESTMENTS IN STEM CELL THERAPIES & RESEARCH
      • RISING AWARENESS ABOUT UMBILICAL CORD STEM CELLS
      • REDUCED RISK OF TISSUE REJECTION IN TRANSPLANTS
    • KEY RESTRAINTS
      • ABSENCE OF A WELL-DEFINED REGULATORY FRAMEWORK FOR STEM CELL THERAPY
      • HIGH COSTS ASSOCIATED WITH STEM CELL PROCEDURES
      • ETHICAL ISSUES AND SOCIAL COMPLEXITIES
      • LESS RESPONSIVENESS IN DEVELOPED ECONOMIES
  1. KEY ANALYTICS
    • IMPACT OF COVID-19 ON STEM CELL MARKET
    • KEY MARKET TRENDS
    • PORTER’S FIVE FORCES ANALYSIS
      • BUYERS POWER
      • SUPPLIERS POWER
      • SUBSTITUTION
      • NEW ENTRANTS
      • INDUSTRY RIVALRY
    • OPPORTUNITY MATRIX
    • VENDOR LANDSCAPE
    • VALUE CHAIN ANALYSIS
    • KEY BUYING CRITERIA
      • PRICE
      • EFFICACY
      • APPLICATION AND EFFECTIVENESS
      • ACCURACY
    • REGULATORY FRAMEWORK
  2. MARKET BY THERAPEUTIC APPLICATION
    • ORTHOPEDIC TREATMENTS
    • INJURIES & WOUNDS
    • ONCOLOGY DISORDERS
    • CARDIOVASCULAR DISORDERS
    • NEUROLOGICAL DISORDERS
    • DIABETES
    • OTHER THERAPEUTIC APPLICATIONS
  3. MARKET BY PRODUCT
    • ADULT STEM CELL
      • HEMATOPOIETIC STEM CELL
      • NEURAL STEM CELL
      • UMBILICAL CORD STEM CELL
      • MESENCHYMAL STEM CELL
      • DENTAL STEM CELL
    • HUMAN EMBRYONIC STEM CELL
    • PLURIPOTENT
    • MOUSE/RAT NEURAL
  4. MARKET BY TECHNOLOGY
    • CELL ACQUISITION
      • BONE MARROW HARVEST
      • UMBILICAL CORD
      • APHERESIS
    • CELL PRODUCTION
      • THERAPEUTIC CLONING
      • IN VITRO FERTILIZATION (IVF)
      • CELL CULTURE
      • ISOLATION
    • CRYOPRESERVATION
    • EXPANSION & SUB-CULTURE
  5. MARKET BY APPLICATION
    • REGENERATIVE MEDICINE
    • DRUG DISCOVERY AND DEVELOPMENT
  6. MARKET BY TREATMENT TYPE
    • ALLOGENEIC STEM CELL THERAPY
    • AUTOLOGIC STEM CELL THERAPY
    • SYNGENEIC STEM CELL THERAPY
  7. GEOGRAPHICAL ANALYSIS
    • NORTH AMERICA
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED STATES
        • CANADA
    • EUROPE
      • MARKET SIZE & ESTIMATES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • UNITED KINGDOM
        • GERMANY
        • FRANCE
        • ITALY
        • BELGIUM
        • POLAND
        • REST OF EUROPE
    • ASIA-PACIFIC
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • COUNTRY ANALYSIS
        • CHINA
        • JAPAN
        • INDIA
        • AUSTRALIA & NEW ZEALAND
        • SOUTH KOREA
        • THAILAND
        • INDONESIA
        • VIETNAM
        • REST OF ASIA-PACIFIC
    • REST OF WORLD
      • MARKET ESTIMATES & SIZES
      • KEY GROWTH ENABLERS
      • KEY CHALLENGES
      • KEY PLAYERS
      • REGIONAL ANALYSIS
        • LATIN AMERICA
        • MIDDLE EAST & AFRICA
  1. COMPETITIVE LANDSCAPE
    • KEY STRATEGIC DEVELOPMENTS
      • ACQUISITIONS
      • PARTNERSHIPS
    • COMPANY PROFILES
      • ALLCELLS LLC
      • BECTON, DICKINSON AND COMPANY (BD)
      • CORNING INC
      • GE HEALTHCARE
      • INTERNATIONAL STEM CELL CORPORATION
      • LOREM CYTORI INC
      • MERCK KGAA (SIGMA ALDRICH)
      • MILTENYI BIOTEC
      • PLURI INC
      • QIAGEN
      • SMITH+NEPHEW PLC
      • STEMCELL TECHNOLOGIES INC
      • STRYKER CORPORATION
      • TAKARA HOLDINGS INC
      • THERMO FISHER SCIENTIFIC INC

LIST OF TABLES  

TABLE 1: MARKET SNAPSHOT – STEM CELL

TABLE 2: EXAMPLES OF APPROVED CELL THERAPY PRODUCTS

TABLE 3: REGULATORY FRAMEWORK

TABLE 4: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 5: GLOBAL STEM CELL MARKET, BY THERAPEUTIC APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 6: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 7: GLOBAL ORTHOPEDIC TREATMENTS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 8: GLOBAL INJURIES & WOUNDS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 9: GLOBAL INJURIES & WOUNDS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 10: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 11: GLOBAL ONCOLOGY DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 12: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 13: GLOBAL CARDIOVASCULAR DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 14: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 15: GLOBAL NEUROLOGICAL DISORDERS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 16: GLOBAL DIABETES MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 17: GLOBAL DIABETES MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 18: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 19: GLOBAL OTHER THERAPEUTIC APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 20: GLOBAL STEM CELL MARKET, BY PRODUCT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 21: GLOBAL STEM CELL MARKET, BY PRODUCT, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 22: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 23: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 24: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 25: GLOBAL HEMATOPOIETIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 26: GLOBAL NEURAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 27: GLOBAL NEURAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 28: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 29: GLOBAL UMBILICAL CORD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 30: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 31: GLOBAL MESENCHYMAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 32: GLOBAL DENTAL STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 33: GLOBAL DENTAL STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 34: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 35: GLOBAL HUMAN EMBRYONIC STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 36: GLOBAL PLURIPOTENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 37: GLOBAL PLURIPOTENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 38: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 39: GLOBAL MOUSE/RAT NEURAL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 40: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 41: GLOBAL STEM CELL MARKET, BY TECHNOLOGY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 42: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 43: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 44: GLOBAL BONE MARROW HARVEST MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 45: GLOBAL BONE MARROW HARVEST MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 46: GLOBAL UMBILICAL CORD MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 47: GLOBAL UMBILICAL CORD MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 48: GLOBAL APHERESIS MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 49: GLOBAL APHERESIS MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 50: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 51: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 52: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 53: GLOBAL THERAPEUTIC CLONING MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 54: GLOBAL IN VITRO FERTILIZATION (IVF) MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 55: GLOBAL IN VITRO FERTILIZATION (IVF) MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 56: GLOBAL CELL CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 57: GLOBAL CELL CULTURE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 58: GLOBAL ISOLATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 59: GLOBAL ISOLATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 60: GLOBAL CRYOPRESERVATION MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 61: GLOBAL CRYOPRESERVATION MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 62: GLOBAL EXPANSION & SUB-CULTURE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 63: GLOBAL EXPANSION & SUB-CULTURE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 64: GLOBAL STEM CELL MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 65: GLOBAL STEM CELL MARKET, BY APPLICATION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 66: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 67: GLOBAL REGENERATIVE MEDICINE MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 68: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 69: GLOBAL DRUG DISCOVERY AND DEVELOPMENT MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 70: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 71: GLOBAL STEM CELL MARKET, BY TREATMENT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 72: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 73: GLOBAL ALLOGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 74: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 75: GLOBAL AUTOLOGIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 76: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 77: GLOBAL SYNGENEIC STEM CELL THERAPY MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 78: GLOBAL STEM CELL MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 79: GLOBAL STEM CELL MARKET, BY GEOGRAPHY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 80: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 81: NORTH AMERICA STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 82: LEADING PLAYERS OPERATING IN NORTH AMERICA STEM CELL MARKET

TABLE 83: EUROPE STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 84: EUROPE STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 85: LEADING PLAYERS OPERATING IN EUROPE STEM CELL MARKET

TABLE 86: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 87: ASIA-PACIFIC STEM CELL MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 88: LEADING PLAYERS OPERATING IN ASIA-PACIFIC STEM CELL MARKET

TABLE 89: REST OF WORLD STEM CELL MARKET, BY REGION, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)

TABLE 90: REST OF WORLD STEM CELL MARKET, BY REGION, FORECAST YEARS, 2022-2030 (IN $ MILLION)

TABLE 91: LEADING PLAYERS OPERATING IN REST OF WORLD STEM CELL MARKET

TABLE 92: LIST OF ACQUISITIONS

TABLE 93: LIST OF PARTNERSHIPS

LIST OF FIGURES 

FIGURE 1: KEY MARKET TRENDS

FIGURE 2: STEM CELL SCREENING STRATEGIES AND THEIR POTENTIAL APPLICATION

FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

FIGURE 4: OPPORTUNITY MATRIX

FIGURE 5: VENDOR LANDSCAPE

FIGURE 6: VALUE CHAIN ANALYSIS

FIGURE 7: KEY BUYING CRITERIA

FIGURE 8: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY THERAPEUTIC APPLICATION, IN 2021

FIGURE 9: GLOBAL STEM CELL MARKET, BY ORTHOPEDIC TREATMENTS, 2022-2030 (IN $ MILLION)

FIGURE 10: GLOBAL STEM CELL MARKET, BY INJURIES & WOUNDS, 2022-2030 (IN $ MILLION)

FIGURE 11: GLOBAL STEM CELL MARKET, BY ONCOLOGY DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 12: GLOBAL STEM CELL MARKET, BY CARDIOVASCULAR DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 13: GLOBAL STEM CELL MARKET, BY NEUROLOGICAL DISORDERS, 2022-2030 (IN $ MILLION)

FIGURE 14: GLOBAL STEM CELL MARKET, BY DIABETES, 2022-2030 (IN $ MILLION)

FIGURE 15: GLOBAL STEM CELL MARKET, BY OTHER THERAPEUTIC APPLICATIONS, 2022-2030 (IN $ MILLION)

FIGURE 16: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY PRODUCT, IN 2021

FIGURE 17: GLOBAL STEM CELL MARKET, BY ADULT STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 18: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY ADULT STEM CELL, IN 2021

FIGURE 19: GLOBAL STEM CELL MARKET, BY HEMATOPOIETIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 20: GLOBAL STEM CELL MARKET, BY NEURAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 21: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 22: GLOBAL STEM CELL MARKET, BY MESENCHYMAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 23: GLOBAL STEM CELL MARKET, BY DENTAL STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 24: GLOBAL STEM CELL MARKET, BY HUMAN EMBRYONIC STEM CELL, 2022-2030 (IN $ MILLION)

FIGURE 25: GLOBAL STEM CELL MARKET, BY PLURIPOTENT, 2022-2030 (IN $ MILLION)

FIGURE 26: GLOBAL STEM CELL MARKET, BY MOUSE/RAT NEURAL, 2022-2030 (IN $ MILLION)

FIGURE 27: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY TECHNOLOGY, IN 2021

FIGURE 28: GLOBAL STEM CELL MARKET, BY CELL ACQUISITION, 2022-2030 (IN $ MILLION)

FIGURE 29: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY CELL ACQUISITION, IN 2021

FIGURE 30: GLOBAL STEM CELL MARKET, BY BONE MARROW HARVEST, 2022-2030 (IN $ MILLION)

FIGURE 31: GLOBAL STEM CELL MARKET, BY UMBILICAL CORD, 2022-2030 (IN $ MILLION)

FIGURE 32: GLOBAL STEM CELL MARKET, BY APHERESIS, 2022-2030 (IN $ MILLION)

FIGURE 33: GLOBAL STEM CELL MARKET, BY CELL PRODUCTION, 2022-2030 (IN $ MILLION)

FIGURE 34: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY CELL PRODUCTION, IN 2021

FIGURE 35: GLOBAL STEM CELL MARKET, BY THERAPEUTIC CLONING, 2022-2030 (IN $ MILLION)

FIGURE 36: GLOBAL STEM CELL MARKET, BY IN VITRO FERTILIZATION (IVF), 2022-2030 (IN $ MILLION)

FIGURE 37: GLOBAL STEM CELL MARKET, BY CELL CULTURE, 2022-2030 (IN $ MILLION)

FIGURE 38: GLOBAL STEM CELL MARKET, BY ISOLATION, 2022-2030 (IN $ MILLION)

FIGURE 39: GLOBAL STEM CELL MARKET, BY CRYOPRESERVATION, 2022-2030 (IN $ MILLION)

FIGURE 40: GLOBAL STEM CELL MARKET, BY EXPANSION & SUB-CULTURE, 2022-2030 (IN $ MILLION)

FIGURE 41: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2021

FIGURE 42: GLOBAL STEM CELL MARKET, BY REGENERATIVE MEDICINE, 2022-2030 (IN $ MILLION)

FIGURE 43: GLOBAL STEM CELL MARKET, BY DRUG DISCOVERY AND DEVELOPMENT, 2022-2030 (IN $ MILLION)

FIGURE 44: GLOBAL STEM CELL MARKET, GROWTH POTENTIAL, BY TREATMENT TYPE, IN 2021

FIGURE 45: GLOBAL STEM CELL MARKET, BY ALLOGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 46: GLOBAL STEM CELL MARKET, BY AUTOLOGIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 47: GLOBAL STEM CELL MARKET, BY SYNGENEIC STEM CELL THERAPY, 2022-2030 (IN $ MILLION)

FIGURE 48: NORTH AMERICA STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 49: UNITED STATES STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 50: CANADA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 51: EUROPE STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)

FIGURE 52: UNITED KINGDOM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 53: GERMANY STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 54: FRANCE STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 55: ITALY STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 56: BELGIUM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 57: POLAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 58: REST OF EUROPE STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 59: ASIA-PACIFIC STEM CELL MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN%)

FIGURE 60: CHINA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 61: JAPAN STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 62: INDIA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 63: AUSTRALIA & NEW ZEALAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 64: SOUTH KOREA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 65: THAILAND STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 66: INDONESIA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 67: VIETNAM STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 68: REST OF ASIA-PACIFIC STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 69: REST OF WORLD STEM CELL MARKET, REGIONAL OUTLOOK, 2021 & 2030 (IN %)

FIGURE 70: LATIN AMERICA STEM CELL MARKET, 2022-2030 (IN $ MILLION)

FIGURE 71: MIDDLE EAST & AFRICA STEM CELL MARKET, 2022-2030 (IN $ MILLION)


    お問合せフォーム

    • レポートのタイトルは自動で入ります。
    • *のある項目は必須項目です。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com